Insider Trading activities of Atyr Pharma Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Atyr Pharma Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Atyr Pharma Inc since year 2005. Table 2 shows the detailed insider transactions of Atyr Pharma Inc since 2005. The reporting company's ticker symbol is LIFE. The reporting company's CIK number is 1339970.
The total value of stock buying since 2005 is $11,765,280.
The total value of stock sales since 2005 is $3,064,915.
The total value of stock option exercises since 2005 is $0.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Atyr Pharma Inc (LIFE).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2018-05 150,000 $149,400 3,209,316 $2,998,912 0 $0
2018-02 0 $0 2,804 $9,532 6,668 $0
2017-11 24,728 $118,694 13,832 $56,471 0 $0
2017-10 4,879 $24,638 0 $0 0 $0
2017-08 132,072 $349,990 0 $0 0 $0
2017-04 2,676 $8,028 0 $0 0 $0
2016-12 155,000 $357,231 0 $0 0 $0
2016-05 12,412 $37,727 0 $0 0 $0
2016-04 300,340 $1,059,572 0 $0 0 $0
2015-05 690,000 $9,660,000 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Atyr Pharma Inc insiders (LIFE)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2018-05-18 Schimmel Paul (Director) Buy 150,000 1.00 149,400
2018-05-16 Ecor1 Capital Fund Qualified, L.p. Sale 2,733,231 .81 2,216,650
2018-05-15 Ecor1 Capital Fund Qualified, L.p. Sale 121,294 1.43 173,086
2018-05-14 Ecor1 Capital Fund Qualified, L.p. Sale 354,791 1.72 609,176
2018-02-08 Amanullah Ashraf (See Remarks) Sale 1,402 3.40 4,766
2018-02-08 Blake John T (Senior Vice President, Finance) Sale 1,402 3.40 4,766
2018-02-07 Amanullah Ashraf (See Remarks) Option Ex 3,334 .00 0
2018-02-07 Blake John T (Senior Vice President, Finance) Option Ex 3,334 .00 0
2017-11-13 Ecor1 Capital Fund Qualified, L.p. Sale 1,083 3.95 4,277
2017-11-10 Ecor1 Capital Fund Qualified, L.p. Sale 5,860 4.00 23,445
2017-11-09 Ecor1 Capital Fund Qualified, L.p. Sale 5,819 4.15 24,148
2017-11-08 Ecor1 Capital Fund Qualified, L.p. Sale 1,070 4.30 4,601
2017-11-01 Ecor1 Capital Fund Qualified, L.p. Buy 24,728 4.80 118,694
2017-10-01 Ecor1 Capital Fund Qualified, L.p. Buy 4,879 5.05 24,638
2017-08-31 Mendlein John (CEO and Director) Buy 37,736 2.65 100,000
2017-08-31 Schimmel Paul (Director) Buy 94,336 2.65 249,990
2017-04-24 Mendlein John (CEO and Director) Buy 124 3.00 372
2017-04-20 Mendlein John (CEO and Director) Buy 1,552 3.00 4,656
2017-04-18 Mendlein John (CEO and Director) Buy 1,000 3.00 3,000
2016-12-21 Schimmel Paul (Director) Buy 10,000 2.28 22,820
2016-12-20 Amanullah Ashraf (Vice President, Manufacturing) Buy 11,000 2.25 24,750
2016-12-20 Schimmel Paul (Director) Buy 15,000 2.27 34,110
2016-12-19 Mendlein John (CEO and Director) Buy 69,000 2.20 151,662
2016-12-16 Schimmel Paul (Director) Buy 10,000 2.40 23,969
2016-12-15 Schimmel Paul (Director) Buy 40,000 2.50 99,920
2016-05-11 Matsuoka Grove (See Remarks) Buy 10,000 3.03 30,299
2016-05-09 Matsuoka Grove (See Remarks) Buy 2,412 3.08 7,428
2016-04-14 Schimmel Paul (Director) Buy 66,219 4.18 276,927
2016-04-13 Schimmel Paul (Director) Buy 9,835 3.85 37,864
2016-04-12 Schimmel Paul (Director) Buy 9,127 3.73 34,007
2016-04-11 Schimmel Paul (Director) Buy 32,659 3.52 114,959
2016-04-08 Schimmel Paul (Director) Buy 85,000 3.22 273,615
2016-04-07 Schimmel Paul (Director) Buy 40,000 3.19 127,600
2016-04-06 Schimmel Paul (Director) Buy 25,000 3.20 80,000
2016-04-05 Mendlein John (CEO and Director) Buy 5,000 3.54 17,675
2016-04-05 Schimmel Paul (Director) Buy 25,000 3.52 88,125
2015-05-12 Deerfield Private Design Fund Iii, L.p. Buy 50,000 14.00 700,000
2015-05-12 Mehra Anand (10% Owner) Buy 320,000 14.00 4,480,000
2015-05-12 Akkaraju Srinivas (Director) Buy 320,000 14.00 4,480,000

Insider trading activities including stock purchases, stock sales, and option exercises of LIFE listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Atyr Pharma Inc (symbol LIFE, CIK number 1339970) see the Securities and Exchange Commission (SEC) website.